| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0760 |
| Trial ID | ChiCTR1800017892 |
| Disease | B-Cell Leukemia | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Safety and efficacy research of Chimeric Antigen Receptor T-Cell targeting CD19 in the treatment of CD19 positive malignant b-cell leukemia or lymphoma |
| Year | 2018 |
| Country | China |
| Company sponsor | Affiliated Hospital of Jining Medical College |
| Cohort 1 | |||||||||
|
|||||||||